Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/2003

01-06-2003 | Original Article

Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882)

An eastern cooperative oncology group study

Authors: Andrea N. Leaf, MD, Kathleen Propert, Chris Corcoran, Paul J. Catalano, Donald L. Trump, Jules E. Harris, Thomas E. Davis

Published in: Medical Oncology | Issue 2/2003

Login to get access
Metadata
Title
Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882)
An eastern cooperative oncology group study
Authors
Andrea N. Leaf, MD
Kathleen Propert
Chris Corcoran
Paul J. Catalano
Donald L. Trump
Jules E. Harris
Thomas E. Davis
Publication date
01-06-2003
Publisher
Humana Press
Published in
Medical Oncology / Issue 2/2003
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1385/MO:20:2:137

Other articles of this Issue 2/2003

Medical Oncology 2/2003 Go to the issue

Original Article

Protective effect of amifostine against cisplatin-induced motor neuropathy in rat

Original Article

Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin

Original Article

Expression of heat shock protein (Hsp) 70 and Hsp 40 in colorectal cancer

Case Report

Breast metastasis from non-small-cell lung carcinoma

Original Article

No association between lymphoma and hepatitis C virus

Case Report

Metastatic choriocarcinoma in a middle-aged man presenting as a right thigh mass with venous thrombosis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits